Elsawy, M., Chavez, J. C., Avivi, I., Larouche, J., Wannesson, L., Cwynarski, K., . . . Kersten, M. J. (2022). Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma. Blood, 140(21), . https://doi.org/10.1182/blood.2022015478
Chicago-Zitierstil (17. Ausg.)Elsawy, Mahmoud, et al. "Patient-reported Outcomes in ZUMA-7, a Phase 3 Study of Axicabtagene Ciloleucel in Second-line Large B-cell Lymphoma." Blood 140, no. 21 (2022). https://doi.org/10.1182/blood.2022015478.
MLA-Zitierstil (9. Ausg.)Elsawy, Mahmoud, et al. "Patient-reported Outcomes in ZUMA-7, a Phase 3 Study of Axicabtagene Ciloleucel in Second-line Large B-cell Lymphoma." Blood, vol. 140, no. 21, 2022, https://doi.org/10.1182/blood.2022015478.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.